Related Experiment Video
Updated: Aug 9, 2026

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
McArdle's disease presenting as treatment resistant polymyositis
J B Higgs1, M Blaivas, J W Albers
1University of Michigan Medical Center, Ann Arbor.
Abstract:
The broad spectrum and often incomplete presentation of polymyositis frequently confound its distinction from other myopathies. In 18 months of screening for myophosphorylase in all muscle biopsy specimens at our institution, 2 cases of McArdle's disease were discovered in patients previously thought to have refractory PM. Given the important treatment implications of this distinction, all patients with "refractory PM" in whom the diagnosis has not been firmly established should be screened for myophosphorylase deficiency.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myasthenia Gravis ll: Pathophysiology
